Miller Anestesia

208. Espinel CH: The FENa test: Use in the differential

diagnosis of acute renal failure. JAMA 236:579–581,

1976.

209. Diamond JR, Yoburn DC: Nonoliguric acute renal

failure associated with a low fractional excretion of

sodium. Ann Intern Med 96:597–600, 1982.

210. Shin B, Mackenzie CF, Helrich M: Creatinine clea-

rance of early detection of posttraumatic renal dys-

function. Anesthesiology 64:605–609, 1986.

211. Brown RS: Renal dysfunction in the surgical patient:

Maintenance of high output state with furosemide.

Crit Care Med 7:63–68, 1979.

212. Brosius FC, Lau K: Low fractional excretion of

sodium in acute renal failure: Role of timing of the

test and ischemia. Am J Nephrol 6:450–457, 1986.

213. Saha H, Mustonen J, Helin H, Pasternack A: Limited

value of the fractional excretion of sodium test in

the diagnosis of acute renal failure. Nephrol Dial

Trasplant 2:79–82, 1987.

214. Steiner RW: Interpreting the fractional excretion of

sodium. Am J Med 77:699–702, 1984.

215. Zarich S, Fang LS, Diamond JR: Fractional excre-

tion of sodium: Exceptions to its diagnostic value.

Arch Intern Med 145:108–112, 1985.

216. Jones LW,Weil MH: Changes in urinary output and

free water clearance in patients with acute circula-

tory failure (shock). J Urol 102:121–125, 1969.

217. Baek SM, Brown RS, Shoemaker WC: Early predic-

tion of acute renal failure and recovery: I.Sequential

measurements of free water clearance. Ann Surg

177:253–258, 1973.

218. Kosinski JP, Lucas CE, Ledgerwood AM: Meaning

and value of free water clearance in injured patients.

J Surg Res 33:184–188, 1982.

219. Sladen RN, Endo E, Harrison T: Two-hour versus

22-hour creatinine clearance in critically ill patients.

Anesthesiology 67:1013–1016, 1987.

220. Wheeler LA, Sheiner LB: Clinical estimation of

creatinine clearance. Am J Clin Pathol 72:27–32,

1979.

221. Greenblatt DJ, Ransil BJ, Harmatz JS, et al: Variabi-

lity of 24-hour urinary creatinine excretion by

normal subjects. J Clin Pharmacol 16:321–328,

1976.

222. Lucas CE, Weaver D, Higgins RF, et al: Effects of

albumin versus non-albumin resuscitation on

plasma volume and renal excretory function.

J Trauma 18:564–570, 1978.

223. Bennett-Guerrero E, et al: Impact of normal saline

based versus balanced salt intravenous fluid repla-

cement on clinical outcomes:A randomized blinded

clinical trial. Anesthesiology 94:A147, 2001.

224. Cittanova ML, Leblanc I, Legendre C, et al: Effect of

hydroxyethylstarch in brain-dead kidney donors on

renal function in kidney-trasplant recipients. Lancet

348:1620–1622, 1996.

225. Peron S, Mouthon L, Guettier C, et al: Hydroxyethyl

starch-induced renal insufficiency after plasma

exchange in a patient with polymyositis and liver

cirrhosis. Clin Nephrol 55:408–411, 2001.

226. Winkelmayer WC, Glynn RJ, Levin R, Avorn J:

Hydroxyethyl starch and change in renal function

in patients undergoing coronary artery bypass graft

surgery. Kidney Int 64:1046–1049, 2003.

227. De Labarthe A, Jacobs F, Blot F, Glotz D: Acute renal

failure secondary to hydroxyethylstarch administra-

tion in a surgical patient. Am J Med 111:417–418,

2001.

228. Schortgen F, Lacherade JC, Bruneel F, et al: Effects

of hydroxyethylstarch and gelatin on renal function

in severe sepsis: A multicentre randomised study.

Lancet 357:911–916, 2001.

229. Boldt J, Brenner T, Lang J, et al: Kidney-specific

proteins in elderly patients undergoing cardiac

surgery with cardiopulmonary bypass. Anesth

Analg 97:1582–1589, 2003.

230. Kumle B, Boldt J, Piper S, et al: The influence of

different intravascular volume replacement regi-

mens on renal function in the elderly. Anesth Analg

89:1124–1130, 1999.

231. Wilkes NJ, Woolf R, Mutch M, et al: The effects of

balanced versus saline-based hetastarch and crysta-

lloid solutions on acid-base and electrolyte status

and gastric mucosal perfusion in elderly surgical

patients. Anesth Analg 93:811–816, 2001.

232. Parekh N: Hyperchloremic acidosis. Anesth Analg

95:1821, 2002.

233. Wilcox C: Regulation of renal blood flow by plasma

chloride. J Clin Invest 71:726–735, 1983.

234. Hansen PB, Jensen BL, Skott O: Chloride regulates

afferent arteriolar contraction in response to depo-

larization. Hypertension 32:1066–1070, 1998.

235. Renkin EM, Robinson RR: Glomerular filtration. N

Engl J Med 290:785–792, 1974.

236. Mauer SM, Steffes MW, Ellis EN, et al: Structural-

functional relationships in diabetic nephropathy. J

Clin Invest 74:1143–1155, 1984.

237. Richards A, Westfall B, Bott P: Renal excretion of

inulin, creatinine, and xylose in normal dogs. Proc

Soc Exp Biol Med 32:73, 1934.

238. Miller BF,Winkler AW: The renal excretion of endo-

genous creatinine in man. comparison with exoge-

nous creatinine and inulin. J Clin Invest 17:31–40,

1938.

239. Skov PE: Glomerular filtration rate in patients with

severe and very severe renal insufficiency: Determi-

ned by simultaneous inulin, creatinine and 125

iothalamate clearance. Acta Med Scand 187:419–

428, 1970.

240. Carcoana OV, Hines RL: Is renal dose dopamine

protective or therapeutic? Yes. Crit Care Clin

12:677–685, 1996.

241. Cottee DB, Saul WP: Is renal dose dopamine pro-

tective or therapeutic? No. Crit Care Clin 12:687–

695, 1996.

242. Holmes CL, Walley KR: Bad medicine: Low-dose

dopamine in the ICU. Chest 123:1266–1275, 2003.

243. Jones D, Bellomo R: Renal-dose dopamine: From

hypothesis to paradigm to dogma to myth and,

finally, superstition? J Intensive Care Med 20:199–

211, 2005.

244. Prins I, Plotz FB, Uiterwaal CS, van Vught HJ: Low-

dose dopamine in neonatal and pediatric intensive

care: A systematic review. Intensive Care Med

27:206–210, 2001.

245. McHugh GJ: Current usage of dopamine in New

Zealand intensive care units. Anaesth Intensive

Care 29:623–626, 2001.

246. Trueta J, Barclay A, Daniel P, et al: Studies on the

Renal Circulation. Oxford, Blackwell Scientific

Publications, 1947.

247. Carriere S, Thorburn G, O’Morchoe C, et al: Intra-

renal distribution of blood flow in dogs during

hemorrhagic hypotension. Circ Res 19:167, 1966.

248. Barger AC, Herd JA: The renal circulation. N Engl

J Med 284:482–490, 1971.

249. Rector JB, Stein JH, Bay WH, et al: Effect of hemo-

rrhage and vasopressor agents on distribution of

renal blood flow. Am J Physiol 222:1125–1131,

1972.

250. Aukland K: Intrarenal distribution of blood flow:

Are reliable methods available for measurements in

man? Scand J Clin Lab Invest 35:481–486, 1975.

251. Aukland K, Loyning EW: Intrarenal blood flow and

para-aminohippurate (PAH) extraction. Acta

Physiol Scand 79:95–108, 1970.

252. Reubi RC, Gossweiler N, Gurtler R: Renal circula-

tion in man studied by means of a dye-dilution

method. Circulation 33:426–442, 1966.

253. Haywood GA, Stewart JT, Counihan PJ, et al: Vali-

dation of bedside measurements of absolute human

renal blood flow by a continuous thermodilution

technique. Crit Care Med 20:659–664, 1992.

254. Muller M, Padberg W, Schindler E, et al: Renocor-

tical tissue oxygen pressure measurements in

patients undergoing living donor kidney trasplanta-

tion. Anesth Analg 87:474–476, 1998.

255. Kram HB, Appel PL, Fleming AW, Shoemaker WC:

Assessment of intestinal and renal perfusion using

surface oximetry. Crit Care Med 14:707–713, 1986.

256. Schott G, Prom T: Intraoperative cortical Po

mea-

surement in kidney trasplantation: The effect of the

calcium antagonist diltiazem. Urologe A 33:415–

421, 1994.

257. Kainuma M, Kimura N, Shimada Y: Effect of acute

changes in renal arterial blood flow on urine oxygen

tension in dogs. Crit Care Med 18:309–312, 1990.

258. Rennie DW, Reeves RB, Pappenheimer JR: Oxygen

pressure in urine and its relation to intrarenal blood

flow. Am J Physiol 195:120–132, 1958.

259. Hong SK, Boylan JW, Tannenberg AM, Rahn H:

Total and partial gas tensions of human bladder

urine. J Appl Physiol 15:115–120, 1960.

260. Thorburn GD, Kopald HH, Herd JA, et al: Intrarenal

distribution of nutrient blood flow determined with

krypton 85 in the unanesthetized dog. Circ Res

13:290–307, 1963.

261. Kainuma M, Yamada M, Miyake T: Continuous

urine oxygen tension monitoring in patients under-

going cardiac surgery. J Cardiothorac Vasc Anesth

10:603–608, 1996.

262. Hollenberg NK, Epstein M, Rosen SM, et al: Acute

oliguric renal failure in man: Evidence for preferen-

tial renal cortical ischemia. Medicine (Baltimore)

47:455–474, 1968.

263. Grunfeld JP, Sabto J, Bankir L, Funck-Brentano JL:

Methods for measurement of renal blood flow in

man. Semin Nucl Med 4:39–50, 1974.

264. Farmelant MH, Burrows BA: The renogram: Phy-

siologic basis and current clinical use. Semin Nucl

Med 4:61–73, 1974.

265. Stevens PE, Gwyther SJ, Hanson ME, et al: Nonin-

vasive monitoring of renal blood flow characteris-

tics during acute renal failure in man.Intensive Care

Med 16:153–158, 1990.

266. Aronson S, Thistlethwaite RJ, Walker R, et al: Safety

and feasibility of renal blood flow determination

during kidney trasplant surgery with perfusion

ultrasonography. Anesth Analg 80:353–359, 1995.

267. Aronson S, Wiencek JG, Feinstein SB, et al:

Assessment of renal blood flow with contrast ultra-

sonography. Anesth Analg 76:964–970, 1993.

268. Wei K, Le E, Bin JP, et al: Quantification of renal

blood flow with contrast-enhanced ultrasound.

J Am Coll Cardiol 37:1135–1140, 2001.

269. Aronson S, Bilotta F, Wienceck J, et al: Assessment

of renal blood flow distribution in dogs with con-

trast ultrasound following dopamine infusion.

Anesth Analg 74:S11, 1992.

270. Trof RJ, Di Maggio F, Leemreis J, Groeneveld AB:

Biomarkers of acute renal injury and renal failure.

Shock 26:245–253, 2006.

271. Bagshaw SM, Langenberg C, Haase M, et al: Urinary

biomarkers in septic acute kidney injury. Intensive

Care Med 33:1285–1296, 2007.

272. Perco P, Pleban C, Kainz A, et al: Protein biomarkers

associated with acute renal failure and chronic

kidney disease. Eur J Clin Invest 36:753–763, 2006.

273. O’Riordan E, Goligorsky MS: Emerging studies of

the urinary proteome: The end of the beginning?

Curr Opin Nephrol Hypertens 14:579–585, 2005.

274. Parikh CR, Edelstein CL, Devarajan P, Cantley L:

Biomarkers of acute kidney injury: Early diagnosis,

pathogenesis, and recovery. J Invest Med 55:333–

340, 2007.

275. Devarajan P: Proteomics for biomarker discovery in

acute kidney injury. Semin Nephrol 27:637–651,

2007.

276. Han WK, Waikar SS, Johnson A, et al: Urinary bio-

markers in the early diagnosis of acute kidney

injury. Kidney Int 73:863–869, 2008.

277. Devarajan P: Emerging biomarkers of acute kidney

injury. Contrib Nephrol 156:203–212, 2007.

278. Nguyen MT, Ross GF, Dent CL, Devarajan P: Early

prediction of acute renal injury using urinary pro-

teomics. Am J Nephrol 25:318–326, 2005.

279. Bonventre JV: Diagnosis of acute kidney injury:

From classic parameters to new biomarkers.Contrib

Nephrol 156:213–219, 2007.

280. Vaidya VS, Bonventre JV: Mechanistic biomarkers

for cytotoxic acute kidney injury. Expert Opin Drug

Metab Toxicol 2:697–713, 2006.

281. Mishra J, Dent C, Tarabishi R, et al: Neutrophil

gelatinase-associated lipocalin (NGAL) as a bio-

marker for acute renal injury after cardiac surgery.

Lancet 365:1231–1238, 2005.

Monitorización de la función renal

1239

Sección III

Control de la anestesia